Source: FirstWord Pharma

Alzprotect: Alzprotect Awarded a Grant from The Michael J. Fox Foundation to Advance Small Molecule Parkinson's Disease Program

Alzprotect, a French biopharmaceutical company has been awarded a USD $338,000 grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF) We are very proud of the recognition o...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Philippe Verwaerde's photo - CEO of Alzprotect

CEO

Philippe Verwaerde

CEO Approval Rating

68/100

Read more